Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02337556 · ClinicalTrials.gov registry record · NA

The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU

A NA study, sponsored by Société des Produits Nestlé (SPN).

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT02337556: Completed NA study, sponsored by Société des Produits Nestlé (SPN).

NCT02337556 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02337556, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.

Primary Outcome

Number of glycemic events outside the serum glucose range of 110-150 mg/dl

Interventions

  • OTHER Peptamen Bariatric
  • OTHER Replete

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2014-11
Est. Completion 2016-12
Phase NA

What the finished NCT02337556 record still lists

NCT02337556 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Peptamen Bariatric is the first listed.

NCT02337556 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02337556 about?

NCT02337556 is a clinical study titled "The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU". To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.

What is the current status of trial NCT02337556?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-11. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02337556?

The interventions under investigation include: Peptamen Bariatric (OTHER), Replete (OTHER).

Who is sponsoring clinical trial NCT02337556?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02337556's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02337556, the US trial registry maintained by the National Library of Medicine. NCT02337556 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.